Contrary to earlier studies, the not-entirely-rare condition known as monoclonal gammopathy of undetermined significance (MGUS) did not appear to raise risk for autoimmune disease when examined in the ...

All patients with multiple myeloma have had MGUS, so what is it? To learn about how multiple myeloma can develop, it’s important to first learn about a plasma cell disorder called monoclonal ...

The rate of MGUS among hospitalized patients over 50 was twice as high as that of the same age group in the general population. Higher rates of MGUS were prevalent among patients who had elevated ...

According to data from a population-based study, monoclonal gammopathy of undetermined significance was significantly associated with only 14 diseases, not 75 as previously believed. These results may ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Two recent papers shine a light on monoclonal gammopathy of undetermined significance (MGUS), a premalignant condition that is prevalent in the general population, affecting about 3% of individuals ...

Patients with multiple myeloma who were previously diagnosed with monoclonal gammopathy of undetermined significance demonstrated improved OS, according to study results. Sigurdur Y. Kristinsson, MD, ...

Patients with multiple myeloma (MM) appear to have better survival if they are found to have monoclonal gammopathy of undetermined significance (MGUS) first, the state that precedes MM and which is ...

GLP-1RA use was associate with lower risks for cardiovascular events among patients with monoclonal gammopathy of undetermined significance and type 2 diabetes. Use of glucagon-like peptide-1 receptor ...

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma are both precursor conditions that can turn into multiple myeloma, a type of cancer that affects plasma cell production ...